Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 16;19(7):2063.
doi: 10.3390/ijms19072063.

Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma

Affiliations
Review

Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma

Patricia Corrales et al. Int J Mol Sci. .

Abstract

Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear hormone receptors that control the transcription of specific genes by binding to regulatory DNA sequences. Among the three subtypes of PPARs, PPARγ modulates a broad range of physiopathological processes, including lipid metabolism, insulin sensitization, cellular differentiation, and cancer. Although predominantly expressed in adipose tissue, PPARγ expression is also found in different regions of the kidney and, upon activation, can redirect metabolism. Recent studies have highlighted important roles for PPARγ in kidney metabolism, such as lipid and glucose metabolism and renal mineral control. PPARγ is also implicated in the renin-angiotensin-aldosterone system and, consequently, in the control of systemic blood pressure. Accordingly, synthetic agonists of PPARγ have reno-protective effects both in diabetic and nondiabetic patients. This review focuses on the role of PPARγ in renal metabolism as a likely key factor in the maintenance of systemic homeostasis.

Keywords: PPARγ; RAAS; kidney; lipid; metabolism; nuclear receptors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PPARγ expression in the kidney and implications for metabolism. PPARγ is expressed in different areas of kidney including the cortex and the medulla, which have different metabolic specializations. Glucose metabolism (blue); Lipid metabolism (purple); Mineral metabolism (green); Blood pressure control (red).
Figure 2
Figure 2
Effects of PPARγ activation in different systems: In the vascular system, PPARγ decreases arterial pressure, relaxes muscular tone, and downregulates RAAS; in adipose tissue, the activation of PPARγ promotes adipogenesis; in β-cells it increases insulin secretion; PPARγ is also anti-inflammatory and from the bone resorption is produced accompanied of release of calcium and phosphate that form stones in the bladder. ANG-II: Angiotensin II; RAAS, Renin Angiotensin Aldosterone System; TGF-β1, transforming growth factor beta 1.

Similar articles

Cited by

References

    1. Khurana S., Bruggeman L.A., Kao H.-Y. Nuclear hormone receptors in podocytes. Cell Biosci. 2012;2:33. doi: 10.1186/2045-3701-2-33. - DOI - PMC - PubMed
    1. Thomas M.C., Jandeleit-Dahm K.A., Tikellis C. The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes. PPAR Res. 2012;2012:456529. doi: 10.1155/2012/456529. - DOI - PMC - PubMed
    1. Higgins L.S., Depaoli A.M. Selective peroxisome proliferator-activated receptor gamma (PPAR gamma) modulation as a strategy for safer therapeutic PPAR gamma activation 1–3. Am. J. Clin. Nutr. 2010;91:267–272. doi: 10.3945/ajcn.2009.28449E. - DOI - PubMed
    1. Vitale S.G., Laganà A.S., Nigro A., La Rosa V.L., Rossetti P., Rapisarda A.M.C., La Vignera S., Condorelli R.A., Corrado F., Buscema M., et al. Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master Minions. PPAR Res. 2016;2016:6517313. doi: 10.1155/2016/6517313. - DOI - PMC - PubMed
    1. Tovar-Palacio C., Torres N., Diaz-Villaseñor A., Tovar A.R. The role of nuclear receptors in the kidney in obesity and metabolic syndrome. Genes Nutr. 2012;7:483–498. doi: 10.1007/s12263-012-0295-5. - DOI - PMC - PubMed